Autologous haematopoietic stem cell transplantation is now well-established as an effective treatment for severe systemic sclerosis with clear demonstration of favourable end-organ and survival outcomes. Treatment-related cardiotoxicity remains the predominant safety concern and contraindicates autologous haematopoietic stem cell transplantation in patients with severe cardiopulmonary disease. In this review, we describe the cardiovascular outcomes of autologous haematopoietic stem cell transplantation recipients, discuss the potential mechanisms of cardiotoxicity and propose future mitigating strategies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242691 | PMC |
| http://dx.doi.org/10.1177/23971983221145639 | DOI Listing |
Publication Analysis
Top Keywords
autologous haematopoietic
16
haematopoietic stem
16
stem cell
16
cell transplantation
16
systemic sclerosis
8
cardiotoxicity autologous
4
haematopoietic
4
stem
4
cell
4
transplantation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!